- TheStreet.com•13 days ago
PharmAthene shares spiked premarket Tuesday premarket, adding to the massive gains seen a day earlier.
- 24/7 Wall St.•13 days ago
Rite Aid, Ralph Lauren, Supervalu, and PharmAthene post new 52-week lows Monday.
- PR Newswire•14 days ago
GAITHERSBURG, Md., Feb. 6, 2017 /PRNewswire/ -- Altimmune, Inc., a clinical stage immunotherapeutics company targeting infectious diseases, announced today that Chief Executive Officer Bill Enright will present at the BIO CEO & Investor Conference on Monday, February 13, 2017 at 4:00 PM ET. The conference will be held at the Waldorf Astoria New York. Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease.
PIP : Summary for PharmAthene, Inc Common Stock - Yahoo Finance
PharmAthene, Inc. (PIP)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.00 - 1.07|
|52 Week Range||0.47 - 3.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||0.59|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|